|Metrics 2.0» Industry Insights» Healthcare/Pharma:|
Sales in the top five European markets showed a 4% constant exchange growth. North America posted a 6% sales growth at $204.85 billion in sales in the 12 months to August. The key therapy growth area for North America was the cytostatics group with a 15% growth at constant exchange. Japan's overall growth at constant exchange was 2%, with $57.14 billion sales in the 12 months to August 2006.
California biomedical industry accounted for $62 billion in revenue in the state last year.